Phospholipase A.sub.2 inhibitors

Details Phospholipase A.sub.2 inhibitors Phospholipase A.sub.2 inhibitors

1987-03-20

1988-12-20

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514212, 514252, 514307, 514317, 514323, 514414, 514416, 514419, 514423, 540597, 540602, 540607, 544360, 544368, 544373, 544386, 546146, 546148, 546149, 546150, 546152, 546155, 546158, 546159, 546192, 546201, 546225, 548483, 548496, 548530, 548367, A61K 31495, A61K 3140, A61K 31445, A61K 3147, A61K 3155, C07D29510, C07D40112, C07D47100

Patent

active

047925558

ABSTRACT:
There are disclosed compounds of the formula ##STR1## wherein R.sup.1 is lower alkyl, lower alkoxycarbonyl lower alkyl, aralkoxycarbonyl, aralkoxycarbonyl lower alkyl or indol-2-yllower alkyl;

REFERENCES:
patent: 4424218 (1984-01-01), Deraedt et al.
Sole et al., Tetrahedron, vol. 42, No. p. 193-198, (1986).
Chemical Abstract, vol. 105, 97917b, (1986).
Chemical Abstract, vol. 73, 120904b, (1970).
Derwent Abstract, 23408 D/14, Continental Pharma., BE-885303, (3/19/81).
Albrecht et al., Chemical Abstract, vol. 100, 1984, 100-192284y.

Affiliated with

Also associated with

Rating

Phospholipase A.sub.2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phospholipase A.sub.2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase A.sub.2 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1909666